> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Reapplix 3C Patch System
- URL: https://www.fdaweb.com/fda-clears-reapplix-3c-patch-system/
- Published: 2017-04-27T12:00:00.000Z
- Updated: 2026-09-14T22:20:21.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5138567

FDA has cleared a Reapplix 510(k) for its 3C Patch System including the 3C Patch Centrifuge. The device is intended to be used at point-of-care for the safe and rapid preparation of platelet-rich plasma gel from a small sample of a patient’s own peripheral blood. The gel produced by the 3C Patch System is topically applied for managing exuding cutaneous wounds, such as leg ulcers, pressure ulcers, and diabetic ulcers and mechanically or surgically-debrided wounds, according to the company.